164 related articles for article (PubMed ID: 20732466)
1. Immunological fingerprinting of group B streptococci: from circulating human antibodies to protective antigens.
Meinke AL; Senn BM; Visram Z; Henics TZ; Minh DB; Schüler W; Neubauer C; Gelbmann D; Noiges B; Sinzinger J; Hanner M; Dewasthaly S; Lundberg U; Hordnes K; Masoud H; Sevelda P; von Gabain A; Nagy E
Vaccine; 2010 Oct; 28(43):6997-7008. PubMed ID: 20732466
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies targeting different cell wall antigens of group B streptococcus mediate protection in both Fc-dependent and independent manner.
Senn BM; Visram Z; Meinke AL; Neubauer C; Gelbmann D; Sinzinger J; Hanner M; Lundberg U; Boisvert H; Reinscheid D; von Gabain A; Nagy E
Vaccine; 2011 May; 29(24):4116-24. PubMed ID: 21496467
[TBL] [Abstract][Full Text] [Related]
3. BibA induces opsonizing antibodies conferring in vivo protection against group B Streptococcus.
Santi I; Maione D; Galeotti CL; Grandi G; Telford JL; Soriani M
J Infect Dis; 2009 Aug; 200(4):564-70. PubMed ID: 19586417
[TBL] [Abstract][Full Text] [Related]
4. BibA: a novel immunogenic bacterial adhesin contributing to group B Streptococcus survival in human blood.
Santi I; Scarselli M; Mariani M; Pezzicoli A; Masignani V; Taddei A; Grandi G; Telford JL; Soriani M
Mol Microbiol; 2007 Feb; 63(3):754-67. PubMed ID: 17212592
[TBL] [Abstract][Full Text] [Related]
5. Role of fibrinogen-binding adhesin expression in septic arthritis and septicemia caused by Streptococcus agalactiae.
Jonsson IM; Pietrocola G; Speziale P; Verdrengh M; Tarkowski A
J Infect Dis; 2005 Oct; 192(8):1456-64. PubMed ID: 16170765
[TBL] [Abstract][Full Text] [Related]
6. Cross-protection between group A and group B streptococci due to cross-reacting surface proteins.
Stâlhammar-Carlemalm M; Areschoug T; Larsson C; Lindahl G
J Infect Dis; 2000 Jul; 182(1):142-9. PubMed ID: 10882591
[TBL] [Abstract][Full Text] [Related]
7. Serotype markers in a Streptococcus agalactiae strain collection from Zimbabwe.
Mavenyengwa RT; Maeland JA; Moyo SR
Indian J Med Microbiol; 2010; 28(4):313-9. PubMed ID: 20966561
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel genomic islands coding for antigenic pilus-like structures in Streptococcus agalactiae.
Rosini R; Rinaudo CD; Soriani M; Lauer P; Mora M; Maione D; Taddei A; Santi I; Ghezzo C; Brettoni C; Buccato S; Margarit I; Grandi G; Telford JL
Mol Microbiol; 2006 Jul; 61(1):126-41. PubMed ID: 16824100
[TBL] [Abstract][Full Text] [Related]
9. Association between low concentrations of antibodies to protein alpha and Rib and invasive neonatal group B streptococcal infection.
Larsson C; Lindroth M; Nordin P; Stålhammar-Carlemalm M; Lindahl G; Krantz I
Arch Dis Child Fetal Neonatal Ed; 2006 Nov; 91(6):F403-8. PubMed ID: 17056838
[TBL] [Abstract][Full Text] [Related]
10. Antigenic determinants of alpha-like proteins of Streptococcus agalactiae.
Maeland JA; Bevanger L; Lyng RV
Clin Diagn Lab Immunol; 2004 Nov; 11(6):1035-9. PubMed ID: 15539502
[TBL] [Abstract][Full Text] [Related]
11. The R-proteins.
Christensen KK; Christensen P
Antibiot Chemother (1971); 1985; 35():114-8. PubMed ID: 3901888
[No Abstract] [Full Text] [Related]
12. Characterization of a novel leucine-rich repeat protein antigen from group B streptococci that elicits protective immunity.
Seepersaud R; Hanniffy SB; Mayne P; Sizer P; Le Page R; Wells JM
Infect Immun; 2005 Mar; 73(3):1671-83. PubMed ID: 15731068
[TBL] [Abstract][Full Text] [Related]
13. The detection of streptococcal antigens using monoclonal antibodies.
Harris MC; Polin RA
Clin Lab Med; 1985 Sep; 5(3):545-60. PubMed ID: 3899481
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of group B protective surface protein, a new cell surface protective antigen of group B streptococci.
Erdogan S; Fagan PK; Talay SR; Rohde M; Ferrieri P; Flores AE; Guzmán CA; Walker MJ; Chhatwal GS
Infect Immun; 2002 Feb; 70(2):803-11. PubMed ID: 11796614
[TBL] [Abstract][Full Text] [Related]
15. Genome analysis reveals pili in Group B Streptococcus.
Lauer P; Rinaudo CD; Soriani M; Margarit I; Maione D; Rosini R; Taddei AR; Mora M; Rappuoli R; Grandi G; Telford JL
Science; 2005 Jul; 309(5731):105. PubMed ID: 15994549
[TBL] [Abstract][Full Text] [Related]
16. Identification of immunoreactive extracellular proteins of Streptococcus agalactiae in bovine mastitis.
Trigo G; Ferreira P; Ribeiro N; Dinis M; Andrade EB; Melo-Cristino J; Ramirez M; Tavares D
Can J Microbiol; 2008 Nov; 54(11):899-905. PubMed ID: 18997846
[TBL] [Abstract][Full Text] [Related]
17. Deletion of repeats in the alpha C protein enhances the pathogenicity of group B streptococci in immune mice.
Gravekamp C; Rosner B; Madoff LC
Infect Immun; 1998 Sep; 66(9):4347-54. PubMed ID: 9712787
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and preclinical evaluation of glycoconjugate vaccines against group B Streptococcus types VI and VIII.
Paoletti LC; Pinel J; Johnson KD; Reinap B; Ross RA; Kasper DL
J Infect Dis; 1999 Sep; 180(3):892-5. PubMed ID: 10438388
[TBL] [Abstract][Full Text] [Related]
19. Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity.
Michel JL; Madoff LC; Kling DE; Kasper DL; Ausubel FM
Infect Immun; 1991 Jun; 59(6):2023-8. PubMed ID: 1674738
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin therapy of neonatal group B streptococcal infections: an overview.
Fischer GW
Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S13-6. PubMed ID: 3041355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
